Equality, Diversity, and Inclusion (EDI) Policy

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

This policy encompasses all forms of discrimination, including those based on age, disability, gender reassignment, marital status, pregnancy, maternity, race, religion, belief, sex, and sexual orientation as defined in the Equality Act 2010.

At Peptides.org, we acknowledge and respect the distinction between assigned birth sex and personal gender identity, thus extending our policy to cover discrimination related to gender identity.

Commitment

At Peptides.org, we expect everyone within our organization and our extended community to uphold principles of fairness, dignity, and respect. We assure that anyone experiencing discrimination, harassment, or bullying can lodge a complaint without fear of victimization or retaliation..

Responsibilities

All Peptides.org team members are charged with fostering an environment of EDI. The Director holds ultimate responsibility for the enforcement of this policy and spearheads its implementation in staff matters and collaborates with the Executive team for its application in Peptides.org’s content and operational activities.

Training

Peptides.org team members must participate in EDI training relevant to their roles. New team members will undergo EDI training as part of their orientation.

Complaints Procedure

Peptides.org advocates for equal treatment, dignity, and respect among all team and community members. Those feeling discriminated against, harassed, or bullied can file a complaint, assured of protection from victimization or retaliation.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Cagrilintide | Breakthrough in Obesity Research

Cagrilintide functions as a non-selective agonist for amylin receptors (AMYRs) and calcitonin receptors (CTRs). It is designed to help manage obesity through mechanisms that reduce food intake and promote weight loss in a dose-dependent manner [1]. Below are the specific mechanisms behind this weight loss effect: The primary mechanism of cagrilintide involves its interaction with AMYRs and CTRs, which are widely expressed in the brain and are crucial for regulating satiety. By activating these receptors, cagrilintide effectively communicates a sense of fullness to the brain's homeostatic centers, particularly in the nucleus tractus solitarius (NTS) and area postrema (AP) of the brainstem. This may reduce patients' desire to eat and decrease their overall food intake, leading to weight loss [8]. Cagrilintide slows gastric emptying and suppresses glucagon secretion. These effects contribute to longer periods of satiety after meals and more stable blood glucose levels, which are beneficial for weight management and metabolic health. However, the effects on gastric emptying and glucagon occur only postprandially when blood sugar levels are elevated, meaning that amylin analogs like cagrilintide do not impede the production of glucagon or normal gastric emptying during normal blood sugar levels [9]. As a result, the peptide can help lower blood sugar but does not pose a risk of hypoglycemia.

Source: peptides.org ↗

Research Based

ResearchPeptides.org follows the strictest sourcing guidelines in the health and nootropics industry. Our focus is to exclusively link to peer-reviewed studies found on respected websites, like PubMed. We focus on finding the most accurate information from the scientific source. Our goal is to provide you with the most scientifically accurate, unbiased, and comprehensive information regarding all research peptides and SARMs. All of our content is written by people with a strong science background, including medical researchers. Our content is continually monitored by an internal peer-review process to ensure accuracy. We strive to never have a piece of inaccurate information on this website. If you feel that any of our content is inaccurate or out-of-date, please contact us at: [email protected] Last Updated September 8, 2025 Uncategorized September 8, 2025

Source: peptides.org ↗

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →